IRIS International closes AlliedPath acquisition

Links shared publicly online about this topic.

977
total visits

IRIS International closes AlliedPath acquisition

IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that it has closed the acquisition of AlliedPath, Inc., a private, early stage high complexity, CLIA-certified laboratory focused on oncology and molecular diagnostics.

View full resource at news-medical.net

Tags: Cancer, Prostate Cancer, Prostate, Hospital, Men's Health, Hospitals, Oncology